Kaunas, Lithuania

Edgaras Misiulis

This inventor holds 1 USPTO granted patent. Top assignee: Kaunas University of Technology. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Edgaras Misiulis: Innovator in Cerebral Vasospasm Detection

Introduction

Edgaras Misiulis is a notable inventor based in Kaunas, Lithuania. He has made significant contributions to the field of medical technology, particularly in the detection of cerebral vasospasm following subarachnoid hemorrhage. His innovative approach utilizes advanced brain imaging techniques to enhance patient care and outcomes.

Latest Patents

Misiulis holds a patent for a "Method and apparatus for early warning of cerebral vasospasm after subarachnoid hemorrhage." This invention focuses on using brain imaging equipment to identify blood leakage within the subarachnoid space. It aims to detect brain zones that are at an increased risk of cerebral vasospasm, thereby providing critical early warnings for medical professionals.

Career Highlights

Edgaras Misiulis is affiliated with Kaunas University of Technology, where he contributes to research and development in medical technologies. His work is instrumental in bridging the gap between engineering and healthcare, showcasing the importance of interdisciplinary collaboration in innovation.

Collaborations

Misiulis has worked alongside esteemed colleagues such as Vytautas Petkus and Algis Dziugys. Their combined expertise enhances the research and development efforts at Kaunas University of Technology, fostering an environment of innovation and discovery.

Conclusion

Edgaras Misiulis exemplifies the spirit of innovation in the medical field through his groundbreaking work on cerebral vasospasm detection. His contributions not only advance medical technology but also improve patient outcomes in critical care settings.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…